Research & Development



  雲瑯放下手里的毛筆,揉揉眼眶道︰“五年聚會一次?”   太宰松開雲瑯,扶著他的肩膀道︰“那就要抓緊了,我這個身子骨已經垮掉了,我怕熬不了幾年。斷龍石還是不要放下來,等我死了,你把我的尸骨以及那些兄弟們的尸骨都放進去,我這些天,把衛仲,黔夫,蓬度的尸體也挖出來了,做成了骨頭架子,你莫要恨他們,一起放進去吧!”CaoPorn   每日傍晚,是雲家莊園最好的時間。超碰免费公开在线视频   雲瑯拍拍繞著他轉圈的老虎的腦袋,很無良地笑道︰“沒錯。”emilybloom哆啪啪视频   太宰搖頭道︰“不成,總要給他們一個交代,我這一覺睡了很長時間嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo